Clinical trial
IPTi in Mozambican Infants for Malaria Prevention
NCT00209794 · Hospital Clinic of Barcelona, Other · Unknown status
Key facts
| NCT number | NCT00209794 |
|---|---|
| Title | IPTi in Mozambican Infants for Malaria Prevention |
| Official title | The Impact of Intermittent Malaria Treatment Administered Through the EPI Scheme on Malaria Morbidity in Mozambican Children |
| Lead sponsor | Hospital Clinic of Barcelona, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Sulfadoxine-Pyrimethamine (Fansidar) |
| Enrollment | 1,498 |
| Start date | Sep 1, 2002 |
| Completion | Dec 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 16, 2006 |
| Countries | Mozambique |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: